![Graham Parry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 $ in data 31/08/2026
Dr. Graham Parry is a Chief Scientific Officer at Electra Therapeutics, Inc. Dr. Parry was previously employed as an Executive Vice President-Translational Sciences by Star Therapeutics, Inc., a Senior Vice President-Translational Sciences by Third Harmonic Bio, Inc., a Vice President-Technical Operations by True North Therapeutics, Inc., a Biology Director by Attenuon, LLC, and a Principal by Motility, Inc. He received his undergraduate degree from Brunel University London and a doctorate degree from the University of London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/09/2026 | 85.504 ( 0,22% ) | 1 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2023 |
| Società | Posizione | Fine |
|---|---|---|
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Corporate Officer/Principal | 01/12/2023 |
| THIRD HARMONIC BIO, INC. | Corporate Officer/Principal | 01/12/2022 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Motility, Inc. | Corporate Officer/Principal | - |
Attenuon, LLC
 Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Brunel University
 Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
